PFS by blinded independent central review (BICR) in the VELIA trial of veliparib (V) plus carboplatin/paclitaxel (CP) and as monotherapy in newly diagnosed patients (pts) with high-grade serous ovarian cancer (HGSC)
Aghajanian, Carol, Bookman, Michael A., Fleming, Gini F., Brady, Mark F., Swisher, Elizabeth M., Steffensen, Karina Dahl, Friedlander, Michael, Okamoto, Aikou, Moore, Kathleen N., Sullivan, Danielle Marie, Fallstrom, Mathias, Dinh, Minh, Ratajczak, Christine, Coleman, Robert L.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Phase 2 study of veliparib plus FOLFIRI ± bevacizumab versus placebo plus FOLFIRI ± bevacizumab in metastatic colorectal cancer
Gorbunova, Vera, Beck, Thaddeus, Hofheinz, Ralf, Garcia-Alfonso, Pilar, Nechaeva, Marina, Cubillo Gracian, Antonio, Mangel, Laszlo, Elez, Elena, Deming, Dustin A., Ramanathan, Ramesh K., Torres, Alison, Sullivan, Danielle Marie, Komarnitsky, Philip B., Berlin, Jordan
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Breast conservation after neoadjuvant chemotherapy for triple-negative breast cancer: Surgical results from an international randomized trial (BrighTNess)
Golshan, Mehra, Loibl, Sibylle, Huober, Jens Bodo, O'Shaughnessy, Joyce, Rugo, Hope S., Wolmark, Norman, McKee, Mark D., Maag, David, Sullivan, Danielle Marie, Giranda, Vincent L., Liu, Xuan, Von Minckwitz, Gunter, Geyer, Charles E., Sikov, William M., Untch, Michael
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Evaluation of homologous recombination deficiency (HRD) status with pathological response to carboplatin +/- veliparib in BrighTNess, a randomized phase 3 study in early stage TNBC
Telli, Melinda L., Metzger, Otto, Timms, Kirsten, Evans, Brent, Vogel, Diana, Wei, Helen, Jones, Joshua Timothy, Wenstrup, Richard J., McKee, Mark D., Sullivan, Danielle Marie, Fallstrom, Mathias, Maag, David, Ansell, Peter J, Sohn, Joohyuk, Chen, Shou-Tung, Martinez, Noelia, Geyer, Charles E., Loibl, Sibylle, Golshan, Mehra
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Veliparib (ABT-888) extended-release formulations: A phase 1 study on safety, pharmacokinetics (PK), and bioavailability in patients with advanced solid tumors
Werner, Theresa Louise, Sachdev, Jasgit C., Swisher, Elizabeth M., Gutierrez, Martin, Kittaneh, Muaiad, Stein, Mark N., Xiong, Hao, Dunbar, Martin, Sullivan, Danielle Marie, Ansell, Peter J, Hetman, Robert, Komarnitsky, Philip, McKee, Mark D., Tan, Antoinette R.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Phase 3 study evaluating efficacy and safety of veliparib (V) plus carboplatin (Cb) or Cb in combination with standard neoadjuvant chemotherapy (NAC) in patients (pts) with early stage triple-negative breast cancer (TNBC)
Geyer, Charles E., O'Shaughnessy, Joyce, Untch, Michael, Sikov, William, Rugo, Hope S., McKee, Mark D., Huober, Jens Bodo, Golshan, Mehra, Giranda, Vincent L., Von Minckwitz, Gunter, Maag, David, Sullivan, Danielle Marie, Wolmark, Norman, McIntyre, Kristi, Ponce Lorenzo, Jose Juan, Metzger Filho, Otto, Rastogi, Priya, Symmans, William Fraser, Liu, Xuan, Loibl, Sibylle
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article